Nonpharmacologic management and prevention of hypertensive disorders in pregnancy

 

Table 2: Meta-analyses of RCTs of dietary and nutrient interventions in the management or prevention of gestational hypertension
Interventions Outcome Total sample size No. of RCTs OR (and 95% CI)
Dietary advice v. no advice33 Preeclampsia 136 1 0.86  (0.33-2.22)
Isoenergetic balanced protein supplementation v. no supplementation34 Pre-eclampsia 782 1 1.00  (0.55-1.88)
Balanced protein and energy supplementation v. no supplementation35 Pre-eclampsia 516 3 1.25  (0.72-2.17)
Restriction of energy intake v. no restriction in overweight women36 Pre-eclampsia 284 2 1.15  (0.55-2.40)
Low v. high salt intake37 Hypertension 36 1 1.78  (0.28-11.52)
Proteinuria 36 1 1.12  (0.07-18.75)
Prophylactic magnesium supplementation v. placebo38,39 Pre-eclampsia 942 2 0.94  (0.61-1.44)
Magnesium supplementation in women with established hypertension40 Use of antihypertensive drugs 58 1 1.54  (0.55-4.28)
Prophylactic calcium supplementation v. placebo41 Hypertension 1729 6 0.44  (0.33-0.59)*
Proteinuric pre-eclampsia 1729 6 0.34  (0.22-0.54)*
Calcium supplementation v. placebo in women with established pre­eclampsia42 Severe pre-eclampsia 75 1 1.05  (0.43-2.59)
Zinc supplementation v. no supplementation43 Hypertension 656 2 0.76  (0.37-1.60)
Iron supplementation v. no supplementation44 Proteinuric hypertension 203 3 0.74  (0.25-2.20)
Folate supplementation v. no supplementation45 Proteinuric hypertension 936 3 1.28  (0.86-1.90)
*Statistically significant.

[Return to text]


| CMAJ October 1, 1997 (vol 157, no 7) / JAMC le 1er octobre 1997 (vol 157, no 7) |

CMA Webspinners / Les fileurs du Web de l'AMC